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Summary
The p75 neurotrophin receptor regulates neuronal
survival, promoting it in some contexts yet activating
apoptosis in others. The mechanism by which the re-
ceptor elicits these differential effects is poorly under-
stood. Here, we demonstrate that p75 is cleaved by
g-secretase in sympathetic neurons, specifically in
response to proapoptotic ligands. This cleavage re-
sulted in ubiquitination and subsequent nuclear trans-
location of NRIF, a DNA binding protein essential for
p75-mediated apoptosis. Inhibition of g-secretase or
expression of a mutant p75 resistant to this protease
prevented receptor proteolysis, blocked NRIF nuclear
entry, and prevented apoptosis. In contrast, overex-
pression of the p75 ICD resulted in NRIF nuclear accu-
mulation and apoptosis. The receptor proteolysis and
NRIF nuclear localization were also observed in vivo
during naturally occurring cell death in the superior
cervical ganglia. These results indicate that p75-medi-
ated apoptosis requires g-secretase dependent re-
lease of its ICD, which facilitates nuclear translocation
of NRIF.
Introduction
The 75 kDa neurotrophin receptor (p75) is a multifunc-
tional signaling protein that interacts with numerous li-
gands and coreceptors to regulate cellular survival, neu-
rite outgrowth, and myelin formation (Barker, 2004). P75
can bind members of the neurotrophin family, including
NGF, brain-derived neurotrophic factor (BDNF), Neuro-
trophin-3 (NT3), and Neurotrophin-4 (NT4) on its own
or in a complex with members of the Trk tyrosine kinase
neurotrophin receptor family (Chao and Hempstead,
*Correspondence: bruce.carter@vanderbilt.edu1995). It can also serve as a coreceptor for myelin pro-
teins, which bind to the Nogo receptor (Wang et al.,
2002; Wong et al., 2002), and recently, p75 was shown
to function in a complex with the neurotensin 3 receptor,
Sortilin, in binding to the proform of NGF (Nykjaer et al.,
2004) and BDNF (Teng et al., 2005). These various
ligands and coreceptors help determine the cellular
effect of p75 activation, although the molecular mecha-
nisms are not well understood.
The ability of p75 to regulate neuronal survival is crit-
ical for the normal development of the vertebrate ner-
vous system. Approximately 50% of the neurons gener-
ated during embryogenesis are eliminated as a normal
pruning process (Oppenheim, 1991). The attrition of
these cells occurs as a result of a limited supply of neu-
rotrophic factors, as well as by active elimination
through stimulation of p75. Based on analysis of p752/2
mice, this receptor has been implicated in the naturally
occurring cell death of neurons in the developing sym-
pathetic ganglia (Bamji et al., 1998; Majdan et al.,
2001), retina (Frade et al., 1996; Frade and Barde,
1998), spinal cord (Frade and Barde, 1999), and basal
forebrain (Yeo et al., 1997; Naumann et al., 2002). P75
also induces apoptosis following a number of CNS
injuries, such as after spinal cord lesion (Beattie et al.,
2002; Harrington et al., 2004) or pilocarpine-induced sei-
zures (Troy et al., 2002).
Despite these numerous functions with important
physiological consequences, p75 signaling mecha-
nisms remain poorly understood. In an effort to under-
stand how the receptor transduces its signals, a number
of proteins have been identified that can bind to its intra-
cellular domain (ICD) (Gentry et al., 2004a), and several
of these have been implicated in apoptosis, including
NRIF (Casademunt et al., 1999; Linggi et al., 2005),
TRAF6 (Khursigara et al., 1999; Yeiser et al., 2004), Rac
(Harrington et al., 2002), NADE (Mukai et al., 2000), and
the MAGE family members NRAGE (Salehi et al., 2000)
and Necdin (Tcherpakov et al., 2002; Kuwako et al.,
2004). Based on analysis of the nrif2/2 mice, NRIF was
shown to be essential for p75-mediated apoptosis in
the developing mouse retina (Casademunt et al., 1999)
and sympathetic neurons from the superior cervical
ganglia (Linggi et al., 2005). NRIF is a DNA binding pro-
tein (Williams et al., 2004, Soc. Neurosci., abstract),
and when ectopically expressed in nontransformed
cells, including sympathetic neurons, it is localized in
the nucleus, in part, and induces apoptosis (Linggi
et al., 2005). Moreover, preventing NRIF’s nuclear entry
abrogated its ability to kill neurons (Geetha et al.,
2005). Thus, although NRIF binds to the ICD of p75
and is an essential component of the receptor’s apopto-
tic signal, it appears to function in the nucleus, raising
the question as to how it gets there.
A number of cell surface receptors transmit their sig-
nals to the nucleus by a direct mechanism, in which
the ICD is liberated by g-secretase mediated intramem-
brane cleavage and translocates to the nucleus; e.g.,
Notch, amyloid precursor protein (APP), and Erb-B4
(Fortini, 2002). Recently, phorbol ester treatment of cell
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cleavage of the receptor, first by the metalloprotease
TACE (Weskamp et al., 2004; Zampieri et al., 2005), fol-
lowed by g-secretase, resulting in release of its ICD
(Jung et al., 2003; Kanning et al., 2003). However, the
physiological significance of this proteolytic processing
remains to be determined.
Here, we report that proBDNF and BDNF induce apo-
ptosis of sympathetic neurons, which is accompanied
by g-secretase mediated cleavage of p75 and NRIF nu-
clear localization. Preventing the cleavage blocks NRIF
nuclear entry and the subsequent apoptosis. These find-
ings suggest that, like Notch and APP, p75 activates
a pathway directly to the nucleus through g-secretase
mediated release of its ICD and that this signal is nec-
essary for nuclear translocation of NRIF, leading to
apoptosis.
Results
Proapoptotic Ligands Induce Cleavage of P75
by g-Secretase in Sympathetic Neurons
Previous studies demonstrated that phorbol ester treat-
ment of cell lines expressing the p75 neurotrophin recep-
tor induced its proteolytic processing, first by TACE,
shedding the extracellular domain and leaving a 30 kDa
membrane bound carboxy-terminal fragment (CTF) (Di-
Stefano and Chelsea, 1990; DiStefano et al., 1993; We-
skamp et al., 2004; Zampieri et al., 2005). Subsequently,
the CTF was cut in the transmembrane domain by the
g-secretase complex, releasing a soluble 25 kDa ICD
(Jung et al., 2003; Kanning et al., 2003). We investigated
whether phorbol ester would similarly induce cleavage of
endogenous p75 in sympathetic neurons, isolated from
rat superior cervical ganglia. Within 30 min of PMA treat-
ment, two p75 fragments, at approximately 30 kDa, the
size of the CTF, and 25 kDa, the size of the ICD, were de-
tected (Figure 1A). As previously reported (Jung et al.,
2003; Kanning et al., 2003), these fragments were rapidly
degraded and could only be detected by pretreating the
neurons with a proteasome inhibitor.
We next investigated whether neurotrophin treatment
could activate the cleavage of p75. Sympathetic neu-
rons were initially cultured in NGF, but in order to evalu-
ate the effect of neurotrophin binding specifically to p75,
without any influence of their binding to TrkA, which is
expressed on these neurons, we removed the NGF
and maintained the neurons in 12.5 mM KCl. Under
these conditions, we did not observe any basal cleavage
of p75, even after 24 hr in the presence of the protea-
some inhibitor; however, treatment with proBDNF or
BDNF, which selectively bind to p75, induced cleavage
of the receptor (Figures 1B and 1C). As with PMA, the
intracellular fragments were not detectable unless a
proteasome inhibitor was present. Curiously, the pro-
teolytic products were not observed until 12 hr of treat-
ment, suggesting other signaling mechanisms precede
the cleavage. We also confirmed that the lower molecu-
lar weight bands were not products of the highly homol-
ogous NRH2/PLAIDD protein (Kanning et al., 2003;
Frankowski et al., 2002), which might be recognized by
our p75 ICD antibody (Figure 1E).
In contrast to proBDNF or BDNF, which induce apo-
ptosis of sympathetic neurons, readdition of NGF, whichpromotes survival through binding to the p75-TrkA com-
plex, did not activate proteolysis of the receptor (Fig-
ure 1D). This did not reflect an inherent inability of this
neurotrophin to stimulate receptor processing because
NGF treatment of RN22 Schwannoma cells also induced
the cleavage (Figure S1A). These cells do not express
TrkA; therefore, it is likely the presence of TrkA in the
neurons that prevents NGF from stimulating p75 prote-
olysis, consistent with previous findings that TrkA ex-
pression inhibits p75 cleavage by g-secretase (Kanning
et al., 2003).
The 25 kDa fragment of p75 observed in response to
BDNF or proBDNF treatment was confirmed to be a
product of g-secretase cleavage by preincubating the
neurons with the g-secretase specific inhibitors Com-
pound E (Seiffert et al., 2000) or DAPT (Dovey et al.,
2001). Neither of these compounds had any effect on
their own, but both blocked the formation of the smaller,
ICD fragment in response to ligand (Figures 2A, 2B,
and 5C).
Cleavage of P75 by g-Secretase Is Necessary
for NRIF Nuclear Translocation in Response
to Ligand
P75-mediated apoptosis in sympathetic neurons re-
quires NRIF (Linggi et al., 2005), a novel zinc finger pro-
tein identified based on its association with the ICD of
p75 (Casademunt et al., 1999). The ability of NRIF to lo-
calize to the nucleus (Casademunt et al., 1999; Gentry
et al., 2004b; Geetha et al., 2005) led us to hypothesize
that its nuclear translocation in response to p75 activa-
tion was dependent on g-secretase-mediated cleavage
of the receptor. To test this hypothesis, we treated
neurons with proBDNF in the presence and absence of
Compound E, the g-secretase inhibitor. By immunoloc-
alization, we found that NRIF was exclusively in the cyto-
plasm of neurons cultured with KCl (Figure 2C) or NGF
(Figure 8D). Following the addition of proBDNF, 90% of
the neurons exhibited nuclear accumulation of NRIF;
however, this translocation was completely blocked in
the presence of Compound E (Figures 2C and 2D).
To further verify the nuclear localization of NRIF after
proBDNF treatment, we prepared nuclear extracts,
and NRIF was detected by immunoprecipitation and
Western blotting. NRIF was only detected in nuclear
lysates after proBDNF treatment (Figure 2E).
NRIF Ubiquitination Is Dependent on P75 Cleavage
The nuclear translocation of NRIF, in response to p75
activation, was recently shown to require polyubiquiti-
nation by the E3 ligase TRAF6 (Geetha et al., 2005).
The ubiquitin chain formed by TRAF6 is not the canoni-
cal lysine 48 linkage, which targets proteins for degra-
dation, but is through lysine 63, which acts more as a
protein interaction motif. In sympathetic neurons, we
observed NRIF polyubiquitinated in response to BDNF
with a time course similar to receptor cleavage (Fig-
ure 3A). To test whether the addition of polyubiquitin
to NRIF required prior processing of the receptor, we
added Compound E to the neurons, which were then
treated with BDNF. As shown in Figure 3A, the g-secre-
tase inhibitor completely ablated ubiquitination of NRIF.
In contrast, receptor cleavage was not altered in
neurons from traf62/2 mice (Figure 3B). These results
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221Figure 1. PMA, proBDNF and BDNF, but Not
NGF, Stimulate P75 Receptor Cleavage in
Sympathetic Neurons
(A) Sympathetic neurons from P3–P4 rats cul-
tured for 2 days with 20 ng/ml of NGF were
treated with a proteasome inhibitor (ZLLLH,
10 mM) alone (Con) or with 1 mM PMA for vary-
ing times and then lysed and subjected to
Western blot analysis with an antibody to
the ICD of p75. Based on their predicted
molecular weight, the arrows indicate the full-
length receptor (w75 kDa, FL), the carboxy-
terminal fragment (w30 kDa, CTF), or the in-
tracellular domain (w25 kDa, ICD).
(B and C) After 2 days in culture with NGF, the
neurons were rinsed to remove the NGF and
refed with media containing 12.5 mM KCl, to
promote survival, and 10 mM ZLLLH alone
(Con) or with 3 ng/ml of proBDNF (B) or 100
ng/ml of BDNF (C). After the indicated times,
the neurons were lysed and subjected to
Western blot analysis with an antibody to
the ICD of p75 (anti-p75 ICD).
(D) Sympathetic neurons were maintained in
10 mM ZLLLH alone (Con) or 100 ng/ml of
NGF and 10 mM ZLLLH for the indicated
time, lysed, and subjected to Western blot
analysis with anti-p75 ICD.
(E) Lysates from the neurons treated 12 hr as
described in (A)–(C) with ZLLLH and 1 mM
PMA, 3 ng/ml proBDNF, or 100 ng/ml BDNF
were Western blotted with an antibody to
NRH2.indicate that receptor cleavage is necessary for the
TRAF6-mediated ubiquitination of NRIF, but p75 pro-
cessing occurs independent of TRAF6.
NRIF Binds to the Liberated ICD of P75
The cleavage of Notch and APP by g-secretase allows
for the binding of the liberated ICD to transcription fac-
tors (Selkoe and Kopan, 2003), and for APP, this pro-
cessing serves as a means of shuttling the transcription
factor Fe65 into the nucleus (Cao and Sudhof, 2001;
Cupers et al., 2001). Therefore, we hypothesized that af-
ter the cleavage of p75, the released ICD would bind to
NRIF. Initially, we tested this in 293 cells stably express-
ing p75. NRIF was transfected into the cells along withTRAF6, which we previously found enhances the ex-
pression of NRIF (Gentry et al., 2004b), and cleavage
was induced by PMA. We observed NRIF coimmunopre-
cipitation with the 25 kDa ICD fragment of p75, as well as
with the CTF and the full-length receptor (Figures 4A and
4B). Inhibiting g-secretase with Compound E prevented
the association between the ICD fragment and NRIF
(Figures 4C and 4D).
We also investigated the association of NRIF and
p75’s g-secretase product in sympathetic neurons.
NRIF was detected in immunoprecipitates of p75 in
the absence of ligand, reflecting an association of the
full-length receptor with NRIF; however, the interaction
of NRIF with the ICD was increased after treatment
Neuron
222Figure 2. Inhibition of g-Secretase Blocks
Ligand-Induced P75 Cleavage and Nuclear
Translocation of NRIF in Sympathetic Neu-
rons
(A and B) Sympathetic neurons were cultured
in NGF (20 ng/ml) for 2 days, and then the
NGF was rinsed off, and the neurons refed
media with 12.5 mM KCl (to promote survival)
and 10 mM ZLLLH in the presence or absence
of the g-secretase inhibitor Compound E
(CpdE). After 1 hr, the neurons were treated
with 3 ng/ml of proBDNF (A), 100 ng/ml of
BDNF (B), or left untreated. After 12 hr, the
neurons were lysed and immunoblotted with
an antibody to the p75 ICD. The arrows indi-
cate the full-length receptor (FL), the car-
boxy-terminal fragment (CTF), or the intracel-
lular domain (ICD).
(C and D) Sympathetic neurons maintained in
12.5 mM KCl (Control) were left untreated or
incubated with 250 nM of Compound E
(CpdE), proBDNF (3 ng/ml), or both (CpdE +
proBDNF). After 30 hr, the neurons were im-
munostained for NRIF (green). The nuclei
were labeled with propidium iodide (red).
The neurons were then imaged by confocal
microscopy (C). (Scale bar, 20 mm). The num-
ber of neurons with nuclear NRIF was quanti-
fied, and the means6 SD are depicted in (D).
(n = 3; asterisk, p < 0.0005.)
(E) Sympathetic neurons maintained in
12.5 mM KCL, as described above, were
treated with or without 3 ng/ml of proBDNF
for 30 hr, and nuclear extracts were prepared.
NRIF was immunoprecipitated and Western
blotted with an antibody to NRIF (top). The
isolation of nuclei was confirmed by blotting
nuclear extracts (NE) and postnuclear super-
natant (PNS) for Histone Deacetylase 1
(HDAC 1) and b-actin (bottom).with BDNF, likely because of the accumulation of the
ICD, and this was reduced by cotreatment with Com-
pound E (Figure 4E). Similarly, when NRIF was immuno-
precipitated, the full-length receptor was detected with
or without BDNF, but the free ICD only associated with
NRIF after ligand treatment (Figure 4F). Taken together,
these findings demonstrate that NRIF associates with
p75 and that g-secretase-mediated cleavage of the re-
ceptor facilitates an interaction between the free ICD
and NRIF.
Inhibition of g-Secretase Prevents
P75-Mediated Apoptosis
The selective ability of proapoptotic ligands to induce
cleavage of p75 and NRIF nuclear translocation sug-
gested that g-secretase-dependent processing of the
receptor was necessary for the cell-death signal in these
neurons. In addition, we found that p75-mediated apo-
ptosis in the neurons required 24 hr, no increase in apo-
ptotic nuclei was observed after 12 hr of BDNF exposure
(data not shown), which is consistent with receptor
cleavage preceding cell death. To test whether p75-
processing by g-secretase was necessary for the apo-
ptotic signal, we preincubated the neurons with various
concentrations of Compound E and then treated them
with proBDNF (Figure 5A) or BDNF (Figure 5B). Both
ligands potently induced neuronal apoptosis, based on
evaluation of the nuclei by DAPI staining; however, thecell death was completely blocked by the g-secretase
inhibitor, which had no effect on its own. Similar results
were obtained with another specific g-secretase inhibi-
tor, DAPT (Figures 5C and 5D).
Expression of P75’s ICD Is Sufficient to Kill Neurons
and Induce NRIF Ubiquitination and Nuclear
Translocation
Because g-secretase has many substrates, we wanted
to rule out the possibility that the g-secretase inhibitors
were blocking the proteolysis of some protein other than
p75, which may be required for proBDNF and BDNF to
induce cell death. Therefore, we assessed whether the
expression of the free p75 ICD alone was sufficient to
kill the neurons. The p75 ICD was expressed in the sym-
pathetic neurons by using an adenovirus, which was
previously shown to elicit cell death in PC12 cells
(Roux et al., 2001). After confirming the expression of
the ICD in the neurons (Figure 6E), we quantified the ap-
optotic nuclei 24 hr after the infection and found a signif-
icant increase in apoptosis (Figures 6A and 6B). Com-
pound E had no effect on the cell death induced by
expression of the ICD, which indicates that it prevented
p75-mediated cell death by blocking cleavage of the re-
ceptor as opposed to other substrates.
In agreement with our results with Compound E in the
neurons, which demonstrated that p75 cleavage is nec-
essary for NRIF to translocate to the nucleus (Figure 2),
P75-Induced Apoptosis Requires Receptor Cleavage
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cient to significantly increase the amount of NRIF in
the nucleus (Figures 6C and 6D). This also corroborates
our previous findings that the nuclear localization of
NRIF is required for p75-mediated apoptosis (Geetha
et al., 2005).
Because our findings suggested that the mechanism
by which NRIF gets targeted to the nucleus, after p75
cleavage, is by the addition of a polyubiquitin chain (Fig-
ure 3) (Geetha et al., 2005), and expression of the ICD
alone resulted in NRIF localizing to the nucleus (Fig-
ure 6C), we hypothesized that expressing this receptor
fragment must be sufficient to induce NRIF modifi-
cation. Indeed, we found that when p75’s ICD was
expressed in neurons by using an adenovirus, NRIF
was ubiquitinated (Figure 6G). Moreover, in contrast to
Figure 3. Inhibition of g-Secretase Blocks Ligand-Induced NRIF
Ubiquitination in Sympathetic Neurons
(A) Sympathetic neurons from P3–P4 rat were cultured in 20 ng/ml of
NGF for 2 days, and then the NGF was rinsed off, and the neurons
refed media containing 12.5 mM KCl (Control) or treated with
250 ng/ml of BDNF for 15 min or 16 hr, with the g-secretase inhibitor
Compound E (CpdE, 100 nM) alone, or pretreated 1 hr with Com-
pound E (CpdE) and then treated with 250 ng/ml of BDNF for
16 hr. The cells were then lysed and NRIF immunoprecipitated and
Western blotted with anti-ubiquitin (top) or anti-NRIF (bottom).
(B) Sympathetic neurons from P4 traf62/2 mice were cultured in
20 ng/ml of NGF for 2 days, NGF removed, and refed with media con-
taining 12.5 mM KCl and 10 mM ZLLLH alone (Control) or with
100 ng/ml of BDNF for 12 hr (BDNF). Then, the neurons were lysed
and immunoblotted with anti-p75 ICD.wild-type neurons, expression of the ICD in neurons
from traf62/2 mice did not mobilize NRIF to the nucleus
(Figure 6H), despite similar levels of ICD expression
(data not shown). Like the endogenous ICD formed by li-
gand activation, the ectopically expressed ICD could be
coimmunoprecipitated with NRIF in wild-type neurons
(Figures 6E and 6F). These results, along with those of
Figure 3 demonstrating that cleavage is necessary for
NRIF ubiquitination, suggest that the proteolytic release
of p75’s ICD is sufficient to stimulate TRAF6-mediated
ubiquitination of NRIF, which facilitates its nuclear trans-
location.
A Noncleavable Mutant of P75 Blocks the Apoptotic
Signal and NRIF Nuclear Translocation
To further confirm that g-secretase must specifically
process p75 in order for the receptor to transduce a
cell-death signal, we used a p75 mutant reported to be
resistant to this protease (Zampieri et al., 2005). This
construct is a chimeric receptor of p75 with the Fas
transmembrane domain (p75-FasTM). Its resistance to
g-secretase was confirmed in 293 cells (Figure 7A),
and its ability to act as a dominant negative and block
the cleavage of endogenous p75 in response to BDNF
was demonstrated in RN22 cells (Figure 7B). We found
that the chimeric receptor was trafficked normally to
the plasma membrane, by immunolocalization (Fig-
ure 7E) and by subcellular fractionation (Figure S2D);
however, its expression prevented the wild-type recep-
tor from interacting with the g-secretase complex. BDNF
treatment of 293 cells expressing p75 resulted in a
ligand-dependent interaction between endogenous pre-
senilin 1, a component of the g-secretase complex, and
the receptor (Figure 7C). In contrast, p75-FasTM did not
associate with presenilin, and it prevented the interac-
tion with wild-type p75 (Figure 7C). The chimeric recep-
tor coimmunoprecipitated with wild-type p75, indicating
that it oligomerizes with the endogenous protein and
thereby prevents its interaction with the g-secretase
complex (Figure S2B).
To determine whether the p75-FasTM could block re-
ceptor-mediated apoptosis in sympathetic neurons, we
transfected this construct, by electroporation, into the
neurons and, after 48 hr, treated the cells with BDNF.
GFP-transfected neurons and those cotransfected with
GFP and wild-type p75 underwent the expected apopto-
sis; however, the noncleavable mutant completely pro-
tected the neurons (Figure 7D). In addition, expression
of p75-FasTM prevented nuclear translocation of NRIF
in response to proBDNF treatment (Figure 7E). These
results indicate that g-secretase mediated proteolysis
of p75 is essential for the nuclear translocation of NRIF
and the subsequent induction of neuronal apoptosis.
Cleavage of P75 and NRIF Nuclear Localization
Occur In Vivo during the Period of Naturally
Occurring Cell Death
In vivo, sympathetic neurons undergo naturally occur-
ring cell death during development and this process
has been suggested to depend, at least in part, on p75
(Bamji et al., 1998; Majdan et al., 2001; Yeiser et al.,
2004). Therefore, we hypothesized that receptor cleav-
age and NRIF nuclear localization should occur during
the period of apoptosis in the superior cervical ganglia
Neuron
224Figure 4. NRIF Associates with the Liberated
Intracellular Domain of P75 in 293 Cells and
Sympathetic Neurons
(A) 293 cells stably expressing the p75 recep-
tor were transfected with pcDNA3-NRIF and
pFlag-TRAF6, or control vectors, and then
treated with 10 mM ZLLLH in the presence
or absence of 1 mM PMA. After 2 hr, the cells
were lysed, and the lysate immunoprecipi-
tated with the p75 ICD antibody and Western
blotted with anti-NRIF (top) or anti-p75 intra-
cellular domain (ICD) (bottom).
(B) The same lysates were also immunopre-
cipitated with anti-NRIF and immunoblotted
by using the antibody to p75’s ICD.
(C and D) 293 cells stably expressing the p75
receptor were cotransfected with pcDNA3-
NRIF and pFlag-TRAF6. 48 hr later, the cells
were pretreated with 10 mM ZLLLH, in the
presence and absence of 250 nM Compound
E, and after 1 hr, 1 mM PMA was added, or
they were left untreated. After 2 hr, the cells
were lysed and the lysate immunoprecipi-
tated with an antibody to p75’s ICD (C) or
NRIF (D) and Western blotted with NRIF or
p75 ICD antibody.
(E and F) Sympathetic neurons from P3–P4
rats were cultured in 20 ng/ml NGF for
2 days, and then the NGF was removed, and
the neurons maintained in 12.5 mM KCl. The
neurons were then pretreated with 10 mM
ZLLLH, in the presence or absence of 250 nM
Compound E, and after 1 hr, 200 ng/ml BDNF
was added, or they were left untreated. After
24 hr, the cells were lysed, immunoprecipi-
tated with antisera to the ICD of p75 (E) or
NRIF (F), and Western blotted with antibodies
to NRIF or p75 ICD.(SCG). Ganglia were isolated from rats at postnatal day 4
(P4), when there is on-going apoptosis, or from day 24
(P24), after neuronal attrition has subsided, and ana-
lyzed for p75 proteolysis by Western blotting. The CTF
and ICD fragments of the receptor were observed at
P4 but not at P24 (Figure 8A). This result was rather sur-
prising given that detection of the ICD in culture was not
possible without proteasome inhibitors and suggests
that a considerable amount of cleavage or a stabilization
mechanism must exist in vivo. We also observed numer-
ous neurons with nuclear NRIF at P4, but at P24, no NRIF
was detected in the nucleus and the signal was very
weak compared to that at P4 (Figure 8B). These results
are consistent with p75 cleavage promoting NRIF nu-
clear translocation.In vivo, the cell death that occurs in the SCG during
development is thought to be primarily a result of limited
supplies of NGF in the target tissue. Hence, the proteol-
ysis of p75 and the nuclear shuttling of NRIF could be the
result of limited NGF. However, we found that NGF with-
drawal was not able to induce receptor cleavage
(Figure 8C) or NRIF movement to the nucleus (Figure 8D).
This result suggests that the in vivo cleavage and NRIF
nuclear translocation is a result of active p75 signaling.
Discussion
The p75 neurotrophin receptor is a key regulator of neu-
ronal apoptosis, both during development and after
injury (Dechant and Barde, 2002; Barde, 2004); however,
P75-Induced Apoptosis Requires Receptor Cleavage
225Figure 5. Inhibition of g-Secretase Prevents
P75-Mediated Apoptosis in Sympathetic
Neurons
(A and B) P3–P4 rat sympathetic neurons
were cultured for 2 days in 20 ng/ml NGF,
and then the NGF was removed and the cells
refed with media containing 12.5 mM KCl
alone (Ctrl), or with varying concentrations
of Compound E (CE), 3 ng/ml proBDNF (PB)
(A), 100 ng/ml BDNF (B), or with both Com-
pound E and proBDNF or BDNF (CE+PB or
CE+B). 48 hr later, the cells were fixed,
stained with DAPI, and apoptotic nuclei
quantified. Shown are the means 6 SD, n = 3
(asterisk, p < 0.002).
(C and D) Sympathetic neurons, cultured as in
(A), were left untreated (Ctrl) or incubated
with DAPT, 100 ng/ml BDNF, or both. The
neurons were lysed after 12 hr and immuno-
blotted with an antibody to p75 ICD (C) or
treated for 48 hr and then fixed, stained with
DAPI, and apoptotic nuclei quantified (D).
Shown are the means 6 SD, n = 3 (asterisk,
p < 0.002).the molecular mechanisms by which it mediates its
effects are not well understood.
In this study, we demonstrate that p75’s apoptotic
signal requires a ligand-dependent cleavage of the re-
ceptor by g-secretase, which releases the intracellular
domain, resulting in nuclear translocation of the DNA
binding protein NRIF through a ubiquitin-dependent
mechanism. Thus, p75 joins the rapidly growing list of
cell-surface proteins that signal directly to the nucleus
through intramembrane proteolysis.
The cleavage of membrane receptors by g-secretase
has recently emerged as a novel and highly conserved
mechanism in receptor mediated signaling (Fortini,
2002; Ebinu and Yankner, 2002). Numerous single-
transmembrane domain proteins have been shown to
undergo this processing (e.g., Notch, APP, Erb-B4,
E-cadherin); however, most have only been shown to
be cleaved in response to phorbol ester treatment.
Only for Notch (Selkoe and Kopan, 2003) and Erb-B4
(Ni et al., 2001) has ligand-dependent cleavage been
demonstrated. Recently, the p75 receptor was also re-
ported to undergo proteolysis by the g-secretase com-
plex in response to phorbol ester (Jung et al., 2003; Kan-
ning et al., 2003). Like many substrates of this protease,
p75 is first cleaved in its extracellular domain by a metal-
loprotease (DiStefano et al., 1993), recently identified as
TNFa convertase (TACE/ADAM-17) (Weskamp et al.,
2004). Evidence for a ligand-dependent cleavage was
provided by Frade (2005), who demonstrated that neu-
rotrophins could induce p75 proteolysis in Schwann
cells; however, the biological significance of this pro-
cessing was not addressed. One of p75’s other ligands,myelin associated glycoprotein (MAG), which interacts
with p75 through the Nogo receptor (Wang et al., 2002;
Wong et al., 2002), was also shown to activate receptor
cleavage by g-secretase, and this processing was es-
sential for the inhibition of neurite outgrowth (Domeni-
coni et al., 2005). Interestingly, this signal has not been
shown to depend on any nuclear events. Thus, the phys-
iological significance of p75 proteolysis in the context of
neurotrophin binding and the potential of the receptor to
signal directly to the nucleus, similar to other g-secre-
tase substrates, remained unclear.
One of the best characterized biological responses of
p75 activation is the induction of cell death. This apopto-
tic signal requires the activation of c-Jun N-terminal ki-
nase (JNK), which has been suggested to involve the re-
ceptor interacting proteins TRAF6 (Yeiser et al., 2004),
Rac (Harrington et al., 2002), and NRAGE (Salehi et al.,
2002). JNK then phosphorylates Bim (Becker et al.,
2004) and Bad (Bhakar et al., 2003), which promote the
release of mitochondrial cytochrome c and caspase ac-
tivation. Curiously, c-Jun does not appear to be required
for p75-mediated apoptosis; however, cycloheximide
prevented the receptor from killing sympathetic neu-
rons, suggesting that macromolecular synthesis is nec-
essary (Palmada et al., 2002). A role for transcription in
p75 signaling was also indicated by the fact that several
of the proteins that associate with the ICD of the recep-
tor can be found in the nucleus and are thought to regu-
late gene expression, e.g., NRIF (Casademunt et al.,
1999; Gentry et al., 2004b), SC-1 (Chittka and Chao,
1999; Chittka et al., 2004), and Necdin (Tcherpakov
et al., 2002). Among these interactors, NRIF has been
Neuron
226Figure 6. Overexpression of the Intracellular Domain of P75 Induces Apoptosis and NRIF Nuclear Translocation and Polyubiquitination in Sym-
pathetic Neurons
(A) Sympathetic neurons, cultured 2 days with 20 ng/ml NGF, were infected with an adenovirus expressing p75 ICD or GFP or left uninfected.
After 24 hr, the neurons were immunostained with the p75 ICD antibody (green). The nuclei were labeled with propidium iodide (red). The neurons
infected with GFP control vector were also immunostained for the ICD of p75 (red). The neurons were then imaged by confocal microscopy. In
neurons overexpresssing the ICD of p75 (arrow), there was an increase in p75 ICD immunoreactivity compared to uninfected and GFP-express-
ing neurons.
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227demonstrated to play an essential role in p75 mediated
apoptosis. It is a novel DNA binding protein (Williams
et al., 2004, Soc. Neurosci., abstract) with Kru¨ppel-
type zinc fingers that was first implicated in p75’s death
signal based on the significant reduction of cell death in
developing retina of nrif2/2 mice (Casademunt et al.,
1999), a phenotype similar to that observed in p752/2
mice (Frade et al., 1996). More recently, it was shown
that sympathetic neurons from these mice are resistant
to p75-induced apoptosis, and ectopic expression of
NRIF in primary cell types resulted in its nuclear accu-
mulation and cell death (Linggi et al., 2005). The nuclear
localization of NRIF is essential for p75-mediated cell
death because a point mutant of NRIF, unable to trans-
locate to the nucleus, was not able to reconstitute the re-
ceptor’s death signal in nrif2/2 sympathetic neurons,
but wild-type NRIF could (Geetha et al., 2005).
These findings raised the question as to how NRIF
gains access to the nucleus, given its interaction with
the ICD of p75. Our current results reveal an answer,
namely, the receptor undergoes a proteolytic cleavage
to release its ICD, thereby facilitating NRIF’s nuclear lo-
calization and the subsequent apoptosis. A similar
mechanism for regulating nuclear signaling has been
demonstrated for several other substrates of g-secre-
tase. In the case of Notch, the ICD enters the nucleus
and binds a repressor complex (CSL) and a coactivator
(Mam), thereby activating Notch target genes (Selkoe
and Kopan, 2003). In a manner more analogous to p75,
the ICD of APP binds to a transcriptional coactivator,
Fe65, and tethers it in the cytosol. After APP cleavage,
Fe65 mobilizes to the nucleus and, together with the his-
tone acetyltransferase Tip60, activates gene transcrip-
tion (Cao and Sudhof, 2001).
For all of these g-secretase substrates, detecting the
endogenous ICD in the nucleus has proven technically
difficult because it is rapidly degraded and only a small
fraction, if any, enters the nucleus (Schweisguth, 2004).
Although for Notch, there is convincing evidence that its
ICD translocates to the nucleus, in the case of many of
the other proteins, it remains controversial. In our exper-
iments, we have not been able to detect any significant
amount of p75’s ICD in the nucleus, even when overex-
pressing the ICD alone (Figure 6A); however, it remains
possible that a fraction is present, below our detection
limits.
The ligand-induced cleavage of p75 was surprisingly
slow, being undetectable until 12 hr (Figure 1). Theselong kinetics would explain why in the original reports
of p75 processing by g-secretase, the authors did not
observe any ligand-dependent proteolysis (Jung et al.,
2003; Kanning et al., 2003) because they did not analyze
the effects of the ligand beyond 1–2 hr. The cleavage ki-
netics we observed for p75 are much longer than those
of Erb-B4 (Ni et al., 2001) and Notch (Berezovska et al.,
2000), suggesting that there are additional signaling
events activated by the receptor that are required prior
to cleavage. It is notable that the activation of JNK by
several cytokines was shown to promote APP and
Notch proteolysis by g-secretase (Liao et al., 2004),
and the activation of JNK by p75 in sympathetic neurons
occurred over a period of several hours (Palmada et al.,
2002; Yeiser et al., 2004). Alternatively, p75 cleavage
may only occur after receptor internalization. The g-sec-
retase-mediated proteolysis of Notch and APP has been
suggested to occur after receptor endocytosis (Kanwar
and Fortini, 2004; Gupta-Rossi et al., 2004; Chang et al.,
2003), although this remains controversial (Chyung
et al., 2005). Recently, p75 internalization after ligand
binding was shown to occur with a long half-life, three
times that for TrkA (Bronfman et al., 2003). Hence, the
delayed appearance of the free p75 ICD may be the re-
sult of a requirement for p75 localizing to an intracellular
compartment prior to cleavage.
One of the mechanisms regulating the internalization
and proteolytic processing of Notch is ubiquitination.
Several E3 ubiquitin ligases have been shown to modu-
late Notch signaling at multiple steps; for example,
Mindbomb and Neuralized are involved in the activation
of Notch ligands, whereas Deltex, Itch, and Nedd4 regu-
late Notch internalization and trafficking (Le Borgne
et al., 2005). Interestingly, one of the proteins shown to
associate with the ICD of p75 is an E3 ubiquitin ligase,
TRAF6. Unlike the classical ubiquitin chain, polymerized
via lysine 48 of ubiquitin, which targets proteins to the
proteasome, TRAF6 catalyzes the formation of a unique
chain linked through lysine 63, and this modification ap-
pears to serve as a protein interaction motif and not pro-
mote degradation (Deng et al., 2000). We recently found
that in response to p75 activation, NRIF undergoes
TRAF6-dependent K63 polyubiquitination at lysine 19
and translocates to the nucleus (Geetha et al., 2005).
Mutation of this lysine in NRIF prevented its ubiquitina-
tion and nuclear translocation, and, unlike wild-type
NRIF, the K19R mutant did not restore p75 mediated ap-
optosis in nrif2/2 sympathetic neurons, demonstrating(B) The sympathetic neurons uninfected or infected with adenovirus expressing GFP or the ICD of p75 as in (A) were untreated or pretreated with
Compound E (100 nM) for 1 hr. Neurons were fixed 24 hr after adenoviral exposure, stained with DAPI, and the apoptotic nuclei quantified. Shown
are the means 6 SD, n = 4 (asterisk, p < 0.001).
(C and D) Sympathetic neurons, incubated with adenovirus expressing GFP or p75 ICD or left uninfected as described above, were immuno-
stained for NRIF after 24 hr (green) and propidium iodide to label nuclei (red). The neurons were then imaged by confocal microscopy (C).
Note the overlap of NRIF and nuclear staining in neurons overexpressing the ICD of p75 (arrows). The neurons infected with GFP control vector
were also immunostained for NRIF (red). (Scale bar, 20 mm.) The neurons with NRIF immunoreactivity in the nucleus were quantified (D). Shown
are the means 6 SD, n = 3 (asterisk, p < 0.0001).
(E and F) Sympathetic neurons were infected with adenovirus expressing GFP or p75 ICD, as described above, the cells were lysed after 24 hr,
immunoprecipitated with antisera to the ICD of p75 (E) or NRIF (F), and Western blotted with anti-NRIF or p75 ICD.
(G) 24 hr after infection of the neurons with adenovirus expressing GFP or p75 ICD, the cells were lysed, immunoprecipitated with NRIF antibody,
and Western blotted with anti-ubiquitin or anti-NRIF.
(H) Sympathetic neurons from traf62/2 animals were cultured in 20 ng/ml NGF, incubated with adenovirus expressing GFP or p75 ICD, or left
uninfected as described above. 24 hr later, the cells were immunostained for NRIF (green) and propidium iodide to label nuclei (red). The neurons
infected with GFP control vector were also immunostained for NRIF (red). The neurons were then imaged by confocal microscopy. (Scale bar,
20 mm.)
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228Figure 7. Expression of a g-Secretase Resistant Mutant of P75 Blocks Receptor-Mediated Apoptosis and NRIF Nuclear Translocation in Sym-
pathetic Neurons
(A) 293 cells were transfected with HA-p75 or the chimera, HA-p75-FasTM. 48 hr after transfection, a proteasome inhibitor (ZLLLH, 10 mM) was
added with or without 100 ng/ml of BDNF for 12 hr. Cell lysates were collected and Western blotted with an antibody to p75 ICD.
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229Figure 8. P75 Cleavage and NRIF Nuclear Lo-
calization Detected In Vivo during the Period
of Naturally Occurring Cell Death
(A) Whole-rat superior cervical ganglia were
isolated at P4 or 24 and Western blotted
with an antibody to the ICD of p75.
(B) Superior cervical ganglia from P4 or P24
were immunostained for NRIF (green) and
propidium iodide for nuclei (red). The tissues
were then imaged by confocal microscopy
(scale bar, 20 mm).
(C) Sympathetic neurons from P3–P4 rats
were cultured in 20 ng/ml of NGF for 2 days,
and then the NGF was removed and neurons
were maintained in media lacking NGF con-
taining antibody to NGF. 24 hr later, the cells
were lysed and Western blotted with anti-p75
ICD.
(D) Sympathetic neurons from P3–P4 rats
were cultured with NGF (20 ng/ml) for
2 days, and then the NGF was removed, and
after 20 hr, the cells were immunostained
for NRIF (green), and the nuclei labeled with
propidium iodode (red) and imaged by confo-
cal microscopy (scale bar, 20 mm).that polyubiquitination and nuclear translocation of
NRIF are required for p75-receptor-mediated neuronal
apoptosis. Here, we demonstrate that the release of
the ICD is necessary for the ubiquitination of NRIF (Fig-
ure 3A); indeed, overexpression of this receptor frag-
ment alone was sufficient to induce this modification
of NRIF (Figure 6G). Taken together, these findings indi-
cate that p75 activation results in receptor cleavage by
g-secretase, which releases the ICD, thereby allowing
TRAF6 to ubiquitinate NRIF, which facilitates its nuclear
translocation.
Experimental Procedures
Cell Culture and Reagents
Sympathetic neurons from P3–P4 rats were isolated from the supe-
rior cervical ganglia (SCG) and cultured as previously described
(Palmada et al., 2002). All experiments with animals were approved
by the Animal Care and Use Committee at Vanderbilt University.
HEK293 and RN22 cells were cultured in high glucose DMEM with
10% fetal bovine serum and penicillin/streptomycin (100 U/ml,
100 mg/ml, respectively) and transfected by the standard calcium
phosphate method.Recombinant, furin-resistant proBDNF was prepared as previ-
ously described (Pang et al., 2004). Recombinant BDNF was gener-
ously provided by Regeneron, Inc. The p75 antiserum was made
with a fusion protein of GST and the full-length ICD.
Neuronal Apoptosis Assay
Sympathetic neurons from P3–P4 rats were cultured in 20 ng/ml of
NGF (Harlan) for 2 days, and then NGF was removed, the cells
rinsed, and switched to media containing anti-NGF (0.1 mg/ml,
Chemicon International) together with 12.5 mM KCl, to promote sur-
vival, with or without the addition of 3 ng/ml proBDNF or 100 ng/ml of
BDNF for 48 hr. In some experiments, neurons maintained in
12.5 mM KCl were treated with Compound E (kindly provided by
Dr. Todd Golde, Mayo Clinic, and Dr. Graham Carpenter, Vanderbilt
University) or DAPT (Calbiochem) in the presence and absence of
3 ng/ml of proBDNF or 100 ng/ml of BDNF for 48 hr. Then cells
were fixed in 4% paraformaldehyde (PFA) and stained with DAPI
(Vector Labs) to score the nuclei as apoptotic or nonapoptotic.
Approximately 300 neurons were counted for each condition.
Immunoprecipitation and Western Blotting
Neurons, cultured as above, were treated with 10 mM of the protea-
some inhibitor ZLLLH (Peptides International) alone or with the addi-
tion of PMA (1mM), proBDNF (3 ng/ml), BDNF (100 ng/ml), or NGF
(100 ng/ml) for various times, as indicated. In some experiments,(B) RN22 cells were transfected with HA-p75, HA-p75-FasTM, or left untransfected. After 48 hr, the cells were treated with 10 mM ZLLLH alone or
together with 100 ng/ml of BDNF for 12 hr, and then cell lysates were collected and analyzed by Western blot with an anti-p75 ICD.
(C) 293 cells were transfected with HA-p75, HA-p75-FasTM, or both, and 48 hr later, the cells were treated with 10 mM ZLLLH alone or together
with 100 ng/ml of BDNF for 12 hr. The cells were lysed and Presenilin 1 immunoprecipitated and Western blotted with anti-p75 ICD or anti-Pre-
senilin 1.
(D) Sympathetic neurons from P3–P4 rats were transfected with GFP alone or cotransfected with GFP and either HA-p75 or HA-p75-FasTM, by
electroporation, and then cultured with NGF (20 ng/ml). After 2 days, the NGF was removed, and the neurons were maintained in media with
12.5 mM KCl alone (empty bars) or with 100 ng/ml of BDNF (black bars). After 48 hr, the cells were stained with DAPI, and the percent of
GFP-positive neurons with apoptotic nuclei quantified. Shown are the means 6 SD, n = 3 (asterisk, p < 0.002).
(E) Sympathetic neurons were cultured and transfected as described in (D) with either HA-p75 or HA-p75-FasTM. 2 days after transfection, the
NGF was removed, and the neurons were maintained in media with 12.5 mM KCl alone (2 proBDNF) or with 3 ng/ml of proBDNF (+ proBDNF) for
30 hr, and then the cells were stained for HA (red) and NRIF (green).
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230the cells were pretreated for 1 hr with the g-secretase inhibitor Com-
pound E or DAPT. Neurons from P3–P4 traf62/2 mice (Naito et al.,
1999) were also treated with 10 mM ZLLLH alone or with the addition
of BDNF (100 ng/ml) for 12 hr. The neurons were then lysed in
Laemmli buffer, sonicated, and subjected to Western blot analysis
with an antibody to the ICD of p75 or to NRIF (Gentry et al.,
2004b). To detect the ICD of p75 in vivo, we isolated whole SCG
from nine animals at P4 or P24.
Transfected 293 cells were treated with 10 mM ZLLLH alone or to-
gether with PMA (1mM) for 2 hr or BDNF (100 ng/ml) for 12 hr. The
RN22 cells were treated with or without NGF (100 ng/ml) for 2 and
12 hr, or with BDNF (100 ng/ml) for 12 hr, in the presence of 10 mM
ZLLLH. For evaluation of the p75 mutants, the 293 or RN22 cells
were transfected with wild-type p75, p75-FasTM, or both and
48 hr later, treated with 10 mM ZLLLH alone or along with
100 ng/ml of BDNF for 12 hr. Cells were harvested and lysed in
NP-40 lysis buffer (10% glycerol, 50 mM Tris-HCl [pH 7.5], 150 mM
NaCl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride [PMSF],
2 mg/ml leupeptin and aprotinin), TGH lysis buffer (0.2% Triton
X-100, 20 mM HEPES [pH 7.2], 20 mM NaCl, 1 mM PMSF,
10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM Na3VO4, and 50 mM
NaF) for the presenilin 1 immunoprecipitation, or SDS lysis buffer
(50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 10 mM NaF, 0.5% Triton
X-100, 1% SDS, 1 mM Na3VO4, 1 mM PMSF, 10 mg/ml leupeptin
and aprotinin) for detecting ubiquitin. The lysates were Western blot-
ted with antibodies to the ICD of p75, NRIF, presenilin 1 (SC-7860,
Santa Cruz Biotechnology) or HA (1:1000, Roche Applied Sciences).
For immunopreciptitation, the neuron or 293 cell lysates were im-
munoprecipitated with affinity-purified anti-NRIF, anti-presenilin 1,
anti-HA, or anti-p75 ICD and then immunoblotted with an antibody
to the ICD of p75 (1:3000), NRIF (1:2000), ubiquitin (1:500,
SC-8017, Santa Cruz), Histone deacetylase 1 (1:1000, Santa Cruz),
b-actin (1:1000, Santa Cruz), or NRH2 (1:2000, generously provided
by Dr. Phil Barker).
Adenoviral Infection of Sympathetic Neurons
Sympathetic neurons from P3–P4 wild-type and traf62/2 animals
were removed from SCG and cultured as described above in NGF
(20 ng/ml) for 2 days and then incubated with adenovirus expressing
GFP or the ICD of p75 at dilutions sufficient to give similar levels of
infection, based on immunofluorescent detection of the expressed
protein. After 24 hr, the neurons were harvested for Western blotting,
immunoprecipitation, or fixed in 4% PFA for immunostaining and
counting apoptotic nuclei. In some experiments the neurons were
treated with Compound E (100 nM) alone or pretreated for 1 hr be-
fore incubation with adenovirus expressing the intracellular domain
of p75.
NRIF Ubiquitination
For NRIF ubiquitination studies, neurons were treated with BDNF
(250 ng /ml) alone for 15 min or 16 hr, or the cells were pretreated
for 1 hr with Compound E (100 nM) followed by treatment with
BDNF for 16 hr. In some experiments, the neurons were infected
with adenovirus expressing GFP or the intracellular domain of p75
for 24 hr. After these treatments, the cells were subjected to Western
blot analysis as described above.
Immunostaining
The sympathetic neurons treated with 3 ng/ml of proBDNF as above
for 30 hr or infected with adenovirus expressing GFP or p75 ICD for
24 hr were fixed in 4% PFA, permeabilized with 0.1% sodium citrate
and 0.1% Triton X-100, blocked with 10% goat serum in PBS, and
incubated with the affinity-purified NRIF antibody (1:100 dilution)
or p75 ICD antibody (1:100) in PBS containing 0.1% Triton X-100, fol-
lowed by incubation with anti-rabbit Alexa 488 or 546 (Molecular
Probes). Nuclei were visualized by propidium iodide, and images
were acquired with a confocal laser imaging system (LSM 510;
Carl Zeiss MicroImaging, Inc.) at 4003. The nuclear localization of
NRIF was quantified blinded by counting 40–50 neurons for each
condition in random confocal images.
For NRIF staining in vivo, SCG’s from P4 or P24 mice were re-
moved, fixed in 4% PFA, and cryosections taken at 12 mm thickness.
The tissues were processed for immunostaining of NRIF as de-
scribed above and nuclei were stained by propidium iodide, andimages were acquired with the confocal laser imaging system at
6003.
Nuclear Extraction Preparation
Sympathetic neurons, cultured as described above on 60 mm dishes
in KCl, were treated with or without 3 ng/ml of proBDNF for 30 hr and
nuclear extracts prepared as described by Dignam et al. (1983). The
nuclear extract was then used to immunoprecipitate NRIF.
Transfection of Sympathetic Neurons
Sympathetic neurons from P3–P4 rats were isolated and dissociated
as previously described (Palmada et al., 2002). The cell suspensions
were then transfected with GFP alone or cotransfected with wild-
type p75 or p75-FasTM by electroporation with program O-03 on
an Amaxa Nucleofactor device. For apoptosis assays, the neurons
were treated as described above, and the nuclei of GFP-positive
neurons were evaluated to score for apoptosis. In each case, at least
130 neurons were counted. For immunostaining, neurons were
transfected with wild-type p75 (HA-p75) or p75-FasTM (HA-p75-
FasTM) receptor and treated with 3 ng/ml of proBDNF or untreated
for 30 hr, and then the neurons were fixed and immunostained for HA
and NRIF with HA mouse monoclonal antibody (1:100, clone 12CA5,
Roche Applied Sciences) and affinity-purified NRIF antibody (1:100)
and visualized with anti mouse Rhodamine Red (Jackson Immuno-
Research Laboratory, Inc.) and anti rabbit Alexa 488 (Molecular
Probes), and images were acquired with a confocal laser imaging
system at 4003.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/50/2/219/DC1/.
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